CAS 872728-81-9
:Mésylate d'étexilate de dabigatran
- Bibr 1048Ms
- Dabigatran Etexilate Mesilate
- Dabigatran Etexilate Methanesulfonate
- Dabigatran etexilate mesylate
- N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester monomethanesulfonat
- Pradaxa
- β-Alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester, methanesulfonate (1:1)
- β-Alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester, monomethanesulfonate
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
Dabigatran Etexilate Mesylate
CAS :Formule :C34H41N7O5·CH4O3SDegré de pureté :>98.0%(HPLC)(T)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :723.85Dabigatran Etexilate Mesylate
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H41N7O5·CH4O3SCouleur et forme :White Off-White Yellow PowderMasse moléculaire :723.30503Dabigatran Etexilate Mesylate
CAS :Formule :C35H45N7O8SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :723.8389Hexyl 2-(4-(((5-((3-Ethoxy-3-Oxopropyl)(Pyridin-2-Yl)Carbamoyl)-1-Methyl-1H-Benzo[d]Imidazol-2-Yl)Methyl)Amino)Benzylidene)Hydrazinecarboxylate Methanesulfonate
CAS :Hexyl 2-(4-(((5-((3-Ethoxy-3-Oxopropyl)(Pyridin-2-Yl)Carbamoyl)-1-Methyl-1H-Benzo[d]Imidazol-2-Yl)Methyl)Amino)Benzylidene)Hydrazinecarboxylate MethanesulfonateFormule :C35H45N7O8SDegré de pureté :98%Masse moléculaire :723.84Dabigatran Etexilate Mesylate
CAS :Dabigatran Etexilate MesylateFormule :C34H41N7O5·CH4O3SDegré de pureté :≥98%Masse moléculaire :723.84Dabigatran Etexilate Mesilate
CAS :Produit contrôléFormule :C34H41N7O5·CH4O3SCouleur et forme :NeatMasse moléculaire :723.84Dabigatran Etexilate Mesylate
CAS :Produit contrôléApplications Nonpeptide, direct thrombin inhibitor. Antithrombotic.
References Hauel, N., et al.: J. Med. Chem., 45, 1757 (2002), Mungall, D., et al.: Curr. Opin. Invest. Drugs, 3, 095 (2002), Stangier, J., et al.: J. Clin. Pharmacol., 45, 555 (2005),Formule :C34H41N7O5·CH4O3SCouleur et forme :NeatMasse moléculaire :723.84Dabigatran Etexilate Mesylate
CAS :Dabigatran Etexilate Mesylate (BIBR 1048MS) is the orally active prodrug of dabigatran. Dabigatran is a reversible and selective, direct thrombin inhibitor.Formule :C34H41N7O5·CH4O3SDegré de pureté :99.91%Couleur et forme :SolidMasse moléculaire :723.84Dabigatran etexilate mesylate
CAS :Ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate methanesulfonateFormule :C35H45N7O8SDegré de pureté :98%Masse moléculaire :723.84Dabigatran etexilate mesylate
CAS :Dabigatran etexilate mesylate is an anticoagulant that is a prodrug of dabigatran, which is not active in the body. It is a synthetic molecule that has been designed to be rapidly converted into dabigatran by esterases in the blood plasma. Dabigatran etexilate mesylate has been shown to have a high bioavailability and low clearance rate, as well as good oral absorption and stability. The drug can be used for people with impaired liver function who are being treated with warfarin or heparin, without any change in dosage requirements. The antidote for dabigatran etexilate mesylate is idarucizumab, which binds to dabigatran in the bloodstream and prevents its binding to thrombin receptors on the surface of blood cells.
Formule :C35H45N7O8SDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :723.84 g/mol










